Discrepancy Between Postnatal and Antenatal Management of Gestational Diabetes in the U.K.
- Fahmy W.F. Hanna, MD, FRCP1,
- John R. Peters, MD, FRCP2,
- Joan Harlow, SRN3 and
- Peter W. Jones, PHD4
- 1Department of Endocrinology, University Hospital of North Staffordshire, Stoke-on-Trent, U.K.
- 2University Hospital of Wales, Cardiff, U.K.
- 3Prince Charles Hospital, Merthyr Tydfil, U.K.
- 4Keele University, Staffordshire, U.K.
- Address correspondence to Dr. F.W.F. Hanna, Consultant Physician and Endocrinologist, University Hospital of North Staffordshire, Stoke-on-Trent ST2 6QG, U.K
There has been no consensus for screening methodology, diagnosis, and management of gestational diabetes mellitus (GDM). We aimed to evaluate routine practice for GDM management across the U.K., including postnatal care. Questionnaires were sent to all members of the Association of British Clinical Diabetologists. They were asked to describe how patients were screened for GDM, the diagnostic criteria, and subsequent management and clinical targets, as well as postnatal care. Centers that did not initially respond were followed up by personal communication. Regional variability trends were assessed by subdividing the U.K. into 10 regions and then analyzing the data with the StatXact χ2 test (version …
